Literature DB >> 12211016

Inhibitor binding alters the directions of domain motions in HIV-1 reverse transcriptase.

N Alpay Temiz1, Ivet Bahar.   

Abstract

Understanding the molecular mechanisms of HIV-1 reverse transcriptase (RT) action and drug inhibition is essential for designing effective antiretroviral therapies. Although comparisons of the different crystal forms of RT give insights into the flexibility of different domains, a direct computational assessment of the effect of inhibitor binding on the collective dynamics of RT is lacking. A structure-based approach is used here for exploring the dynamics of RT in unliganded and inhibitor-bound forms. Non-nucleoside RT inhibitors (NNRTI) are shown to interfere directly with the global hinge-bending mechanism that controls the cooperative motions of the p66 fingers and thumb subdomains. The net effect of nevirapine binding is to change the direction of domain movements rather than suppress their mobilities. The second generation NNRTI, efavirenz, on the other hand, shows the stronger effect of simultaneously reorienting domain motions and obstructing the p66 thumb fluctuations. A second hinge site controlling the global rotational reorientations of the RNase H domain is identified, which could serve as a target for potential inhibitors of RNase H activity. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211016     DOI: 10.1002/prot.10183

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  32 in total

1.  Escherichia coli adenylate kinase dynamics: comparison of elastic network model modes with mode-coupling (15)N-NMR relaxation data.

Authors:  N Alpay Temiz; Eva Meirovitch; Ivet Bahar
Journal:  Proteins       Date:  2004-11-15

Review 2.  Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Authors:  Nicolas Sluis-Cremer; N Alpay Temiz; Ivet Bahar
Journal:  Curr HIV Res       Date:  2004-10       Impact factor: 1.581

3.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  iGNM: a database of protein functional motions based on Gaussian Network Model.

Authors:  Lee-Wei Yang; Xiong Liu; Christopher J Jursa; Mark Holliman; A J Rader; Hassan A Karimi; Ivet Bahar
Journal:  Bioinformatics       Date:  2005-04-28       Impact factor: 6.937

5.  Coupling between catalytic site and collective dynamics: a requirement for mechanochemical activity of enzymes.

Authors:  Lee-Wei Yang; Ivet Bahar
Journal:  Structure       Date:  2005-06       Impact factor: 5.006

6.  The change of protein intradomain mobility on ligand binding: is it a commonly observed phenomenon?

Authors:  Semen O Yesylevskyy; Valery N Kharkyanen; Alexander P Demchenko
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

7.  Packing regularities in biological structures relate to their dynamics.

Authors:  Robert L Jernigan; Andrzej Kloczkowski
Journal:  Methods Mol Biol       Date:  2007

8.  Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.

Authors:  Emmanuele Crespan; Giada A Locatelli; Reynel Cancio; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

9.  The HIV-1 p66 homodimeric RT exhibits different conformations in the binding-competent and -incompetent NNRTI site.

Authors:  Naima G Sharaf; Zhaoyong Xi; Rieko Ishima; Angela M Gronenborn
Journal:  Proteins       Date:  2017-09-26

10.  Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.

Authors:  Martin T Christen; Lakshmi Menon; Nataliya S Myshakina; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2012-08-31       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.